Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Dermatologic 2

Conditions

Melanoma 324Skin Neoplasms 164Carcinoma, Basal Cell 90Keratosis, Actinic 62Lymphoma, T-Cell, Cutaneous 60Breast Neoplasms 59Leukemia, Lymphocytic, Chronic, B-Cell 47Precursor Cell Lymphoblastic Leukemia-Lymphoma 46Mycosis Fungoides 46Lymphoma, Non-Hodgkin 46Sezary Syndrome 44Lymphoma, Follicular 44Lymphoma, Large B-Cell, Diffuse 43Lymphoma, B-Cell, Marginal Zone 43Lymphoma, Mantle-Cell 42Burkitt Lymphoma 42Hodgkin Disease 41Carcinoma, Squamous Cell 41Neoplasms 40Lymphoma, Large-Cell, Immunoblastic 40Multiple Myeloma 39Lymphoma 39Leukemia, Myeloid, Acute 35Leukemia, Myeloid, Accelerated Phase 32Myeloproliferative Disorders 31Leukemia, Myeloid, Chronic-Phase 31Congenital Abnormalities 30Leukemia, Hairy Cell 29Sarcoma 28Primary Myelofibrosis 28

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Melanosis × Dermatologic × Clear all
NCT04834167 2023-11-30

OneDoc Picopulseâ„¢ for the Treatment of Melasma Among Malaysian Women

Universiti Tunku Abdul Rahman

Phase NA Completed
32 enrolled
Dermatologic

Melanoma, Melanosis, Skin Diseases

NCT01444989 2018-08-15

AKRQ

Wake Forest University Health Sciences

Phase NA Completed
150 enrolled
Dermatologic

Melanosis, Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡